Improving the Quality of Care for Patients Harboring ALK+ NSCLC
CME activity here: https://reachmd.com/programs/cme/improving-quality-care-patients-harboring-alk-nsclc/12631/
This CME activity will review molecular testing for ALK rearrangements, approved and emerging therapeutic options for the first-line treatment of ALK+ NSCLC and treatment upon disease progression, treatment selection and sequencing, and efficacy and safety data of ALK inhibitors.
HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches
This CME/CMLE-accredited online course is designed to help Pathologists, laboratory professionals, and other members of the cancer care team apply the latest scientific evidence when evaluating HER2 status and be comfortable having an open dialogue surrounding challenging HER2 cases and how treatment is informed by HER2 status. Faculty also present information about how the emerging science around HER2‐low may impact patient care.
Improving Quality of Care and Shared Decision-Making in Myelofibrosis
CME Activity: https://reachmd.com/programs/cme/part-1-improving-quality-care-and-shared-decision-making-myelofibrosis/11997/
This activity will review recent advances and critical concepts that affect outcomes, including symptom burden, molecular diagnostics, prognostic risk stratification scores, and the treatment and management of MF.
This 1-hour online CME/CMLE module is designed to help you increase your scientific knowledge around recent approvals of combination immuno-oncology (I-O) therapies, emerging I-O biomarkers, and biomarker testing challenges.
To claim CME credit for this course, please register at https://store.ascp.org/productlisting/productdetail?productId=131699358
This one-hour interactive, online CME/CMLE module is designed to help pathologists and laboratory professionals gain a deeper scientific understanding of recent advances in the diagnosis and management of HER2-positive and HER2-low breast cancer.
To claim CME credit for this course, please register at https://store.ascp.org/productlisting/productdetail?productId=123811419&_ga=2.269259641.929308495.1598834085-509862140.1542376895
Supported by an independent educational grant from Daiichi Sankyo, Inc.
The CMS Equity Plan for Improving Quality in Medicare outlines how the U.S. Centers for Medicare & Medicaid Services plans to advance health equity by improving the quality of care provided to minority and other underserved Medicare beneficiaries.
The framework for the plan consists of three interconnected domains:
1. Increasing understanding and awareness of disparities
2. Creating and sharing solutions
3. Accelerating implementation of effective actions
In order to achieve complete equity, the framework and plan calls for continuous improvement and action—starting with the six priorities:
Priority 1: Expand the Collection, Reporting, and Analysis of Standardized Data
Priority 2: Evaluate Disparities Impacts and Integrate Equity Solutions Across CMS Programs
Priority 3: Develop and Disseminate Promising Approaches to Reduce Health Disparities
Priority 4: Increase the Ability of the Health Care Workforce to Meet the Needs of Vulnerable Populations
Priority 5: Improve Communication and Language Access for Individuals with Limited English Proficiency and Persons with Disabilities
Priority 6: Increase Physical Accessibility of Health Care Facilities
7 April 2020 is the day to celebrate the work of nurses and midwives and remind world leaders of the critical role they play in keeping the world healthy. Nurses and other health workers are at the forefront of COVID-19 response - providing high quality, respectful treatment and care, leading community dialogue to address fears and questions and, in some instances, collecting data for clinical studies. Quite simply, without nurses, there would be no response.
In this International Year of the Nurse and the Midwife, World Health Day will highlight the current status of nursing and around the world. WHO and its partners will make a series of recommendations to strengthen of the nursing and midwifery workforce.
WHO has released the State of the World’s Nursing Report 2020
Immuno Oncology Virtual Cancer Committee
To claim CME credit for this course, please register at:
From "Crossing the Quality Chasm: A New Health System for the 21st Century" released in March 2001:
Six Aims for Improvement:
A health care system that achieves major gains in these six areas would be far better at meeting patient needs. Patients would experience care that is safer, more reliable, more responsive to their needs, more integrated, and more available, and they could count on receiving the full array of preventive, acute, and chronic services that are likely to prove beneficial. Clinicians and other health workers also would benefit through their increased satisfaction at being better able to do their jobs and thereby bring improved health, greater longevity, less pain and suffering, and increased personal productivity to those who receive their care.
The rapid rate of breakthroughs in immuno-oncology (IO) continues to disrupt diagnostic processes and workflows in cancer care. As more patients with different types of cancers are treated with immune checkpoint inhibitor therapy, pathologists and laboratory professionals need to work closely with oncologists and other cancer clinicians to optimize IO biomarker testing and ensure that patients are treated with the right agents.
This live 1.5-hour CME multidisciplinary, interactive panel discussion will highlight practical ways to overcome barriers around IO biomarker testing, communication among members of the multidisciplinary cancer care team, and the use of immune checkpoint inhibitor therapy to improve patient care.
Sign up to receive updates: